Last reviewed · How we verify
NCT03812276
Neodent Implantable Devices of GM Line
trial testing Dental Implants in Jaw, Edentulous in 43 participants. Completed in 28 January 2023.
10 January 2023
Quick facts
| Lead sponsor | Neodent |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 43 |
| Start date | 14 February 2019 |
| Primary completion | 10 January 2023 |
| Estimated completion | 28 January 2023 |
| Sites | 2 locations across Brazil |
Drugs / interventions tested
- Dental Implants
Conditions studied
- Jaw, Edentulous — all drugs for Jaw, Edentulous →
- Jaw, Edentulous, Partially — all drugs for Jaw, Edentulous, Partially →
Sponsor
Neodent
Who can join
18 and older, any sex, with Jaw, Edentulous or Jaw, Edentulous, Partially. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Acqua GM (Grand Morse) Helix implants present an optimized implant design with adapted treatment protocol, allowing for treatment of patients with different bone qualities. The objective of the study is to prospectively collect clinical data to confirm the long-term safety and clinical performance of Acqua GM Helix implants and GM prosthetic abutments in daily dental practice setting, by means of success and survival rates of these devices. Devices will be used according to standard routine in daily practice, according to all indications as specified by the manufacturer in the IFU (instructions for use). patients will be followed for 36 months after implant placement.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03812276
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dental Implants
Trials testing the same drug.
- NCT04545840 — Prospective Neodent® Zirconia System Study · unknown
- NCT06420713 — Horizontal Bone Augmentation of Alveolar Ridge · NA · completed
- NCT04800406 — Marginal Bone Height Changes Around Two Different Surface Treated Dental Implants Supporting Mandibular Complete Overden · NA · completed
Other recruiting trials for Jaw, Edentulous
Currently open trials in the same condition.
- NCT05355792 — Multicenter Study to Evaluate the Clinical Outcome of the OmniTaper EV Implant in Single Tooth Restorations · NA · active not recruiting
Other Neodent trials
Trials by the same sponsor.
- NCT05260892 — Incisors Single-Unit Rehabilitation With Narrow GM Implants · unknown
- NCT05082038 — Mandibular Full-arch Rehabilitation With Internal Hexagonal and Conical Connection Implants · NA · unknown
- NCT04545840 — Prospective Neodent® Zirconia System Study · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03812276 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neodent
- Last refreshed: 10 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03812276.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing